This program will provide an overview of federal regulation of the cannabis industry, in light of the Department of Justice’s recent rescission of the Cole Memorandum, a 2013 memo that symbolized a major shift in drug enforcement.
Presented by Jonathan Havens, Co-Chair of Saul Ewing Arnstein & Lehr’s Cannabis Law Practice, the program will also briefly explore the role of the Federal Drug Administration (FDA) and Drug Enforcement Administration (DEA) in cannabis regulation, and finally, will conclude with insights as to what’s in the store for the future of the cannabis industry.
Jonathan Havens counsels clients on regulatory, compliance, enforcement, and transactional matters related to products regulated by the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), and the U.S. Consumer Product Safety Commission (CPSC). Companies in the consumer health care products, life sciences, cosmetics, tobacco, and medical cannabis industries, among others, turn to Jonathan for advice on how to get and keep their products on the market. He advises companies throughout the product life cycle, including product development, formulation, manufacture, distribution, and promotion. More specifically, Jonathan handles matters involving labeling, good manufacturing practice (GMP), quality system regulation (QSR), product design, and registration and listing, to name a few. When disputes, including litigation, arise relating to these and other issues, Jonathan helps clients navigate them. This includes preparation for FDA inspections, response to inspectional observations (FDA Form 483) and warning letters, managing product recalls, and resolving import and export issues. He also counsels clients through business transactions that involve oversight by myriad federal and state agencies.
Beyond his FDA, FTC, and CPSC work, Jonathan’s experience extends to matters involving the U.S. Department of Agriculture (USDA), the U.S. Drug Enforcement Administration (DEA), U.S. Customs and Border Protection (CBP), a wide array of state and municipal agencies, state attorneys general, and district attorneys. His deep understanding of the complex regulatory and statutory requirements that govern a wide range of products and services is enhanced by his experience working in government and on Capitol Hill. Before entering private practice, Jonathan served as regulatory counsel with FDA, where he focused on compliance and enforcement related to promotion, advertising, and labeling. Jonathan has also held legislative and government affairs positions in which he facilitated the development and execution of strategic communications to members of Congress and their staff aides, and managed several areas of policy and drafted legislative proposals.
Great class. Thanks!
Jonathan's presentation was excellent.
In depth, broad brushed presentation. Well done.
A very well informed and clearly communicated session. Would highly recommend even if not practicing in the area.
Very informative and current. Would like updates on developments. Really liked the presenter.
One of the better courses i've taken. Jonathan is excellent and his materials were also very thorough. His references to the resources he commonly uses were key to the course being useful and helpful to anyone who might want to get more involved in a practice like this.
Great discussion of complex and variable topic.
Very topical discussion and legal analysis, super presentation.
Excellent presentation on a subject I knew nothing about. Thanks!
Excellent speaker. Really did a good job of bringing up to date the issues in this field.
Very solid presenter.
updates for this subject please!
Excellent presentation! Very informative.
Unlimited CLE Subscription gives you access to take almost any course from our catalog and earn as much CLE credit as you need.